You are here

Article Text

Article menu
Download PDFPDF
Electronic pages
Psychological interventions
Mindfulness-based cognitive therapy delays depressive relapse across demographic subgroups
  1. Graham Meadows,
  2. Frances Shawyer
  1. Monash University, Melbourne, Victoria, Australia
  1. Correspondence to Professor Graham Meadows, Southern Synergy, Department of Psychiatry, Monash University, Administration, Research & Training (ART) Building, Dandenong Hospital, 126-128 Cleeland St, Dandenong VIC 3175, Australia; Graham.meadows{at}monash.edu

http://dx.doi.org/10.1136/eb-2016-102526

Statistics from Altmetric.com

    ABSTRACT FROM: Kuyken W, Warren FC, Taylor RS, et al. Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: an individual patient data meta-analysis from randomized trials. JAMA Psychiatry 2016;73:565–74.OpenUrl

    What is already known on this topic

    Several meta-analyses of about 20 year’s work on randomised controlled trials (RCTs) with mindfulness-based cognitive therapy for depression (MBCT)1 have concluded that MBCT is efficacious in reducing relapse/recurrence where people have had at least three major depressive episodes (MDEs).

    Methods of the study

    In an update to a previous meta-analysis trial identification process,2 2555 potentially relevant studies published or accepted for publication between November 2010-November 2014 were identified through a systematic literature search using EMBASE, PsycINFO, PubMed/MEDLINE, Scopus, Web of Science and the Cochrane Controlled Trials Register. Of these, 766 studies were screened against study inclusion criteria; 8 full-text publications assessed for eligibility. Inclusion criteria were: (1) randomised trials of MBCT for prevention …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/